CLOs on the Move

Y-mAbs Therapeutics

www.ymabs.com

 
YmAbs has a powerful set of capabilities for the development of biologics. Our product development team includes some of the most talented and experienced professionals in the antibody industry.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.ymabs.com
  • 750 Third Avenue 9th Floor
    New York, NY USA 10017
  • Phone: 212.847.9841

Executives

Name Title Contact Details
Jonathan Malz
Head of U.S. Compliance and Commercial Law Profile

Similar Companies

Bioduro-Sundia

BioDuro-Sundia provide its biopharma customers a single end-to-end solution from early stage drug discovery to late stage manufacturing.

BioShield Technologies

BioShield Technologies is a Norcross, GA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Pierrel Research

Pierrel Research is a Wayne, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bayer Healthcare Pharmacuticals

Committed to developing novel diagnostics and therapeutics that address unmet medical needs, Berlex, Inc., a U.S. affiliate of Schering AG, Germany (NYSE:SHR), develops and markets diagnostic imaging agents, treatments in the areas of female healthcare

Tectonic Therapeutic

Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs). With our proprietary GEODe™ platform, we are targeting the most difficult, previously undruggable receptors in the class, aiming to unlock their therapeutic utility to develop new treatments for a broad range of patients with important unmet needs.